ReviewGlobal health action2026
Epidemiology of gestational diabetes mellitus in Latin America and the Caribbean: a scoping review.
Review in Global health action, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gestational diabetes mellitus (GDM) is a major maternal health concern associated with adverse outcomes for mothers and their offspring. In Latin America and the Caribbean (LAC), its burden is heightened by socioeconomic inequalities, limited prenatal care, and high obesity rates, while evidence for other determinants remains fragmented and heterogeneous. This scoping review aimed to identify, describe, and categorize existing research on the prevalence, incidence, determinants, and risk factors of GDM in LAC. We conducted a scoping review following JBI guidance and PRISMA-ScR. Embase, MEDLINE/PubMed, Web of Science, SciELO, and LILACS were searched from inception to December 2025. Eligible studies included observational studies reporting GDM prevalence, incidence, diagnostic criteria, or risk factors in LAC. Two reviewers independently screened records and extracted data. Findings were synthesized descriptively. Fifty‑six studies from nine LAC countries were included, mainly from Brazil and Mexico. Studies were predominantly cross-sectional, cohort, and case-control designs conducted in hospital or prenatal care settings. Diagnostic approaches varied, with IADPSG (39.3%), WHO (25.0%), and ADA (16.1%) as the most frequently used criteria. GDM prevalence ranged from 3.0% to 61.0%, and incidence estimates varied substantially. The most frequently reported determinants and risk factors were advanced maternal age, overweight and obesity, family history of diabetes, previous GDM, prior macrosomia, and hypertension. Behavioral and social determinants were less frequently assessed. Variability in GDM prevalence across LAC highlights the need for standardized regional screening and prospective, population-based research. Reducing the regional GDM burden requires integrating clinical interventions targeting modifiable risk factors and improved continuity of care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.